1-4 cm甲状腺乳头状癌可行腺叶切除术:10年倾向评分匹配复发分析
本研究纳入2345例1-4 cm甲状腺乳头状癌患者,比较腺叶切除与全切的复发结局。经倾向评分匹配后中位随访9.8年,两组无病生存率无显著差异,多因素分析显示手术范围非独立预后因素,支持腺叶切除作为此类患者的初始术式。
要点
- 1-4 cm PTC患者腺叶切除与全切的10年无病生存率无显著差异。
- 肿瘤大小不应作为全切的绝对指征。
- 多因素分析显示手术范围非结构性疾病持续/复发的独立危险因素。
核心结论
- 在控制主要预后因素后,1-4 cm PTC患者行腺叶切除的无病生存率与全切相似。
- 支持腺叶切除作为该类患者的初始手术方式,肿瘤大小不应成为全切的绝对指征。
研究设计与样本
- 回顾性队列研究,纳入2345例1-4 cm PTC患者,排除侧颈淋巴结转移或初始远处转移者。
- 按年龄、性别、肿瘤大小、甲状腺外侵犯、多灶性、颈部淋巴结转移进行1:1倾向评分匹配,每组381例。
主要发现
- 腺叶切除383例(16.3%),全切1962例(83.7%)。
临床怎么用
- 对于1-4 cm PTC且无侧颈淋巴结转移或远处转移的患者,腺叶切除可作为初始手术选择。
- 决策时应综合评估其他预后因素,而非仅依据肿瘤大小决定全切。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Current guidelines allow lobectomy as treatment for 1-4 cm papillary thyroid carcinomas (PTCs), as previous studies reported no clear survival advantages for total thyroidectomy (TT). However, data on recurrence based on surgical extent are limited. METHODS: This study enrolled 2345 patients with 1-4 cm PTC. Those with lateral cervical lymph node metastasis or initial distant metastasis were excluded. Disease-free survival (DFS) was compared after 1:1 propensity score matching by age, sex, tumor size, extrathyroidal extension, multifocality, and cervical lymph node metastasis. RESULTS: Lobectomy was performed in 383 (16.3%) and TT in 1962 (83.7%) patients. In the matched-pair analysis (381 patients in each group), no significant difference in DFS was observed during the median follow-up of 9.8 years (hazard ratio [HR] = 1.35 [confidence interval (CI) 0.40-1.36], p = 0.33). When stratified by tumor size, DFS did not differ between the group with 1-2 cm tumors and that with 2-4 cm tumors (HR = 1.57 [CI 0.75-3.25], p = 0.228; HR = 0.93 [CI 0.30-2.89], p = 0.902, respectively). Multivariate analysis showed that the surgical extent did not play an independent role in structural persistent/recurrent disease development (HR = 1.43 [CI 0.72-2.83], p = 0.306). CONCLUSION: Patients with 1-4 cm PTCs who underwent lobectomy exhibited DFS rates similar to those who underwent TT after controlling for major prognostic factors. This supports the feasibility of lobectomy as initial surgical approach for these patients and emphasizes that tumor size should not be an absolute indication for TT.
引用
- Song E, Han M, Oh HS, et al. Lobectomy Is Feasible for 1-4 cm Papillary Thyroid Carcinomas: A 10-Year Propensity Score Matched-Pair Analysis on Recurrence. Thyroid. 2018. PMID: 30375260. doi:10.1089/thy.2018.0554
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。